1-12 of 12
Charles Lu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Induction Chemotherapy with or without Erlotinib in Patients with Head and Neck Squamous Cell Carcinoma Amenable for Surgical Resection

Xiuning Le, Frederico O. Gleber-Netto, M. Laura Rubin, Yun Qing, Robyn Du, Merrill Kies, George Blumenschein, Jr, Charles Lu, Faye M. Johnson, Diana Bell, Jeff Lewis, Jiexin Zhang, Lei Feng, Kaye Wilson, Kathrina Marcelo-Lewis, Jing Wang, Lawrence Ginsberg, Maura Gillison, J. Jack Lee, Funda Meric-Berstam, Gordon B. Mills, William N. William, Jr, Jeffrey N. Myers, Curtis R. Pickering
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (13): 2796–2806.
https://doi.org/10.1158/1078-0432.CCR-21-3239
Published: 01 July 2022
View article titled, Induction Chemotherapy with or without Erlotinib in Patients with Head and Neck Squamous Cell Carcinoma Amenable for Surgical Resection
Open the PDF for Induction Chemotherapy with or without Erlotinib in Patients with Head and Neck Squamous Cell Carcinoma Amenable for Surgical Resection in another window
Includes: Supplementary data
Journal Articles

Correction: Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck

Renata Ferrarotto, Moran Amit, Priyadharsini Nagarajan, M. Laura Rubin, Ying Yuan, Diana Bell, Adel K. El-Naggar, Jason M. Johnson, William H. Morrison, David I. Rosenthal, Bonnie S. Glisson, Faye M. Johnson, Charles Lu, Frank E. Mott, Bita Esmaeli, Eduardo M. Diaz, Jr, Paul W. Gidley, Ryan P. Goepfert, Carol M. Lewis, Randal S. Weber, Jennifer A. Wargo, Sreyashi Basu, Fei Duan, Shalini S. Yadav, Padmanee Sharma, James P. Allison, Jeffrey N. Myers, Neil D. Gross
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (8): 1735.
https://doi.org/10.1158/1078-0432.CCR-22-0468
Published: 14 April 2022
View article titled, Correction: Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck
Open the PDF for Correction: Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck in another window
Includes: Supplementary data
Journal Articles

Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck

Renata Ferrarotto, Moran Amit, Priyadharsini Nagarajan, M. Laura Rubin, Ying Yuan, Diana Bell, Adel K. El-Naggar, Jason M. Johnson, William H. Morrison, David I. Rosenthal, Bonnie S. Glisson, Faye M. Johnson, Charles Lu, Frank E. Mott, Bita Esmaeli, Eduardo M. Diaz, Jr, Paul W. Gidley, Ryan P. Goepfert, Carol M. Lewis, Randal S. Weber, Jennifer A. Wargo, Sreyashi Basu, Fei Duan, Shalini S. Yadav, Padmanee Sharma, James P. Allison, Jeffrey N. Myers, Neil D. Gross
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (16): 4557–4565.
https://doi.org/10.1158/1078-0432.CCR-21-0585
Published: 15 August 2021
View article titled, Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck
Open the PDF for Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck in another window
Includes: Supplementary data
Journal Articles

A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non–Small Cell Lung Cancer

Tina Cascone, Boris Sepesi, Heather Y. Lin, Neda Kalhor, Edwin R. Parra, Mei Jiang, Myrna C.B. Godoy, Jianjun Zhang, Frank V. Fossella, Anne S. Tsao, Vincent K. Lam, Charles Lu, Frank E. Mott, George R. Simon, Mara B. Antonoff, Reza J. Mehran, David C. Rice, Carmen Behrens, Annikka Weissferdt, Cesar Moran, Ara A. Vaporciyan, J. Jack Lee, Stephen G. Swisher, Don L. Gibbons, Ignacio I. Wistuba, William N. William, Jr., John V. Heymach
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (14): 3525–3536.
https://doi.org/10.1158/1078-0432.CCR-19-4180
Published: 15 July 2020
View article titled, A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non–Small Cell Lung Cancer
Open the PDF for A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Germline Predictors of Outcome in Non-small Cell Lung Cancer

Xifeng Wu, Charles Lu, Yunqing Ye, Joe Chang, Hushan Yang, Jie Lin, Jian Gu, Waun Hong, David Stewart, Margaret Spitz
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (19_Supplement): PL07-02.
Published: 15 August 2014
View article titled, Germline Predictors of Outcome in Non-small Cell Lung Cancer
Journal Articles

Genetic Variants in Cell Cycle Control Pathway Confer Susceptibility to Lung Cancer

Wei Wang, Margaret R. Spitz, Hushan Yang, Charles Lu, David J. Stewart, Xifeng Wu
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (19): 5974–5981.
https://doi.org/10.1158/1078-0432.CCR-07-0113
Published: 01 October 2007
View article titled, Genetic Variants in Cell Cycle Control Pathway Confer Susceptibility to Lung Cancer
Open the PDF for Genetic Variants in Cell Cycle Control Pathway Confer Susceptibility to Lung Cancer in another window
Journal Articles

Aberrant Promoter Methylation Profile and Association with Survival in Patients with Non–Small Cell Lung Cancer

Jian Gu, David Berman, Charles Lu, Ignacio I. Wistuba, Jack A. Roth, Marsha Frazier, Margaret R. Spitz, Xifeng Wu
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (24): 7329–7338.
https://doi.org/10.1158/1078-0432.CCR-06-0894
Published: 22 December 2006
View article titled, Aberrant Promoter Methylation Profile and Association with Survival in Patients with Non–Small Cell Lung Cancer
Open the PDF for Aberrant Promoter Methylation Profile and Association with Survival in Patients with Non–Small Cell Lung Cancer in another window
Journal Articles

Expression of Telomere-Associated Genes as Prognostic Markers for Overall Survival in Patients with Non–Small Cell Lung Cancer

Xin Lin, Jian Gu, Charles Lu, Margaret R. Spitz, Xifeng Wu
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (19): 5720–5725.
https://doi.org/10.1158/1078-0432.CCR-05-2809
Published: 04 October 2006
View article titled, Expression of Telomere-Associated Genes as Prognostic Markers for Overall Survival in Patients with Non–Small Cell Lung Cancer
Open the PDF for Expression of Telomere-Associated Genes as Prognostic Markers for Overall Survival in Patients with Non–Small Cell Lung Cancer in another window
Journal Articles

High Mutagen Sensitivity in Peripheral Blood Lymphocytes Predicts Poor Overall and Disease-Specific Survival in Patients with Stage III Non–Small Cell Lung Cancer Treated with Radiotherapy and Chemotherapy

Joe Y. Chang, Ritsuko Komaki, Ryohei Sasaki, Zhongxing Liao, Craig W. Stevens, Charles Lu, Frank V. Fossella, Pamela K. Allen, James D. Cox, Margaret R. Spitz, Xifeng Wu
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (8): 2894–2898.
https://doi.org/10.1158/1078-0432.CCR-04-2176
Published: 18 April 2005
View article titled, High Mutagen Sensitivity in Peripheral Blood Lymphocytes Predicts Poor Overall and Disease-Specific Survival in Patients with Stage III Non–Small Cell Lung Cancer Treated with Radiotherapy and Chemotherapy
Open the PDF for High Mutagen Sensitivity in Peripheral Blood Lymphocytes Predicts Poor Overall and Disease-Specific Survival in Patients with Stage III Non–Small Cell Lung Cancer Treated with Radiotherapy and Chemotherapy in another window
Journal Articles

Value of p16 INK4a and RASSF1A Promoter Hypermethylation in Prognosis of Patients with Resectable Non–Small Cell Lung Cancer

Jie Wang, J. Jack Lee, Luo Wang, Diane D. Liu, Charles Lu, You-Hong Fan, Waun Ki Hong, Li Mao
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (18): 6119–6125.
https://doi.org/10.1158/1078-0432.CCR-04-0652
Published: 24 September 2004
View article titled, Value of <em>p16</em> <sup>INK4a</sup> and <em>RASSF1A</em> Promoter Hypermethylation in Prognosis of Patients with Resectable Non–Small Cell Lung Cancer
Open the PDF for Value of <em>p16</em> <sup>INK4a</sup> and <em>RASSF1A</em> Promoter Hypermethylation in Prognosis of Patients with Resectable Non–Small Cell Lung Cancer in another window
Journal Articles

Phase I Study of the Farnesyltransferase Inhibitor Lonafarnib with Paclitaxel in Solid Tumors

Fadlo R. Khuri, Bonnie S. Glisson, Edward S. Kim, Paul Statkevich, Peter F. Thall, Michael L. Meyers, Roy S. Herbst, Reginald F. Munden, Craig Tendler, Yali Zhu, Sandra Bangert, Elizabeth Thompson, Charles Lu, Xue-Mei Wang, Dong M. Shin, Merrill S. Kies, Vali Papadimitrakopoulou, Frank V. Fossella, Paul Kirschmeier, W. Robert Bishop, Waun Ki Hong
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (9): 2968–2976.
https://doi.org/10.1158/1078-0432.CCR-03-0412
Published: 06 May 2004
View article titled, Phase I Study of the Farnesyltransferase Inhibitor Lonafarnib with Paclitaxel in Solid Tumors
Open the PDF for Phase I Study of the Farnesyltransferase Inhibitor Lonafarnib with Paclitaxel in Solid Tumors in another window
Journal Articles

A Phase I Study of Topotecan/Paclitaxel Alternating with Etoposide/Cisplatin and Thoracic Irradiation in Patients with Limited Small Cell Lung Cancer

Charles Lu, Ritsuko Komaki, Jin Soo Lee, Dong M. Shin, J. Lynn Palmer, Brenda J. Coldman, Katherine M. Pisters, Jonathan M. Kurie, Frank V. Fossella, Bonnie S. Glisson
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (6): 2085–2091.
Published: 01 June 2003
View article titled, A Phase I Study of Topotecan/Paclitaxel Alternating with Etoposide/Cisplatin and Thoracic Irradiation in Patients with Limited Small Cell Lung Cancer
Open the PDF for A Phase I Study of Topotecan/Paclitaxel Alternating with Etoposide/Cisplatin and Thoracic Irradiation in Patients with Limited Small Cell Lung Cancer in another window